Contrasting ASP Isotopes (ASPI) and Its Competitors

ASP Isotopes (NASDAQ:ASPI) is one of 18 publicly-traded companies in the “Miscellaneous chemical products” industry, but how does it contrast to its peers? We will compare ASP Isotopes to related businesses based on the strength of its profitability, institutional ownership, valuation, analyst recommendations, risk, dividends and earnings.

Institutional & Insider Ownership

1.5% of ASP Isotopes shares are held by institutional investors. Comparatively, 72.6% of shares of all “Miscellaneous chemical products” companies are held by institutional investors. 14.1% of shares of all “Miscellaneous chemical products” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares ASP Isotopes and its peers top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
ASP Isotopes	N/A	-$4.95 million	-3.11
ASP Isotopes Competitors	$1.26 billion	$32.20 million	11.27

ASP Isotopes’ peers have higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Analyst Ratings

This is a summary of current ratings and price targets for ASP Isotopes and its peers, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	0	0	0	0	N/A
ASP Isotopes Competitors	31	329	310	6	2.43

As a group, “Miscellaneous chemical products” companies have a potential upside of 14.98%. Given ASP Isotopes’ peers higher probable upside, analysts clearly believe ASP Isotopes has less favorable growth aspects than its peers.

Profitability

This table compares ASP Isotopes and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	N/A	-116.87%	-90.49%
ASP Isotopes Competitors	-21.17%	0.85%	-7.44%

Summary

ASP Isotopes peers beat ASP Isotopes on 8 of the 9 factors compared.

ASP Isotopes Company Profile

ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company also Uranium-235, an isotope of uranium for carbon-free energy industry. ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.